학술논문
Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor.
Document Type
Article
Source
Subject
*MYASTHENIA gravis
*INTERLEUKIN-17
*IMMUNOGLOBULINS
*T helper cells
*NICOTINIC acetylcholine receptors
*
*
*
*
Language
ISSN
1590-1874
Abstract
Among the AChR-IgG seronegative, up to 40% of MG patients have antibodies binding to muscle-specific kinase (MuSK) protein. Myasthenia gravis (MG) is an antibody-mediated disorder of the neuromuscular junction (NMJ) characterized by skeletal muscle weakness and fatigability. [Extracted from the article]